What a pharmaceutics viva tests
A pharmaceutics viva asks you to explain how a medicine is designed, made, tested and used safely. The examiner may start with a formulation problem, then change one detail to see whether you can reason through the consequences. For example: why choose a suspension rather than a solution, what could make a tablet dissolve more slowly, or what controls matter when preparing a sterile product?
There is no single international pharmaceutics viva format. The structure, subject coverage and assessment criteria depend on your course and examining body. Check your course handbook and official examination guidance for those details. The practice stations below are general examples, not claims about a particular examination.
A useful spoken answer is organised, not memorised word-for-word. Try this sequence:
- Clarify the goal. Identify the patient, route, intended release and main product constraint.
- Name the governing principle. Connect the formulation choice to solubility, stability, delivery or manufacturing.
- Apply it to the case. State what you would choose and why.
- Identify a failure mode. Explain how the product could fail and how you would detect or reduce that risk.
- Finish with a check. Name the relevant test, control or information you would confirm.
Keep your first response concise, then expand when asked. If a number or standard depends on a specific product or jurisdiction, say what you would verify rather than guessing.
A practice examiner strip in MySummaries can help you keep those priorities in view:
The emphasis labels here are a practice framework, not an official marking scheme. Use the terminology and criteria supplied by your own course.
Build stations from the material you need to know
A useful station begins with a realistic decision, not a request to recite a chapter. You might be asked to compare two dosage forms, troubleshoot a process, or explain what a quality test tells you. Practise a few different types of problem so that you can transfer your knowledge when the examiner adds a complication.
For each station, prepare a short opening structure rather than a fixed script. Think about the formulation objective, the material or process variables, the likely risk, and the test that would reveal it. The table below shows four practice stations and the opening prompt for each.
A station list in MySummaries makes those prompts easy to revisit and lets you identify which ones you have actually practised aloud:
The scores and attempt counts are practice examples. For each station, record whether you answered in a logical order, supported your choices with pharmaceutics, and named a relevant control or test. Below are three stations worked through as spoken answers.
Station 1: Immediate-release tablet dissolution
The prompt is about troubleshooting, so do not jump straight to changing an excipient. First separate possible formulation causes from process variation and test-method issues. A strong answer makes clear that dissolution depends on the drug and the conditions around it, and that the investigation should compare the affected batch with a suitable reference.
A useful way to reason is to consider wetting and disintegration, the drug’s particle properties and solubility, and manufacturing variables such as compression. Then describe how you would investigate those possibilities using batch records, appropriate physical tests and the dissolution method. Avoid claiming that one test result alone establishes the cause.
A recorded attempt in MySummaries can be marked against practice criteria so you can see whether your answer explains both the mechanism and the investigation:
Examiner
A batch of immediate-release tablets is dissolving more slowly than the previous batch. Talk me through the formulation and process causes you would investigate first.
You compared the affected batch with the previous batch and proposed checking records, but the sequence of checks was not fully clear.
ImproveStart by confirming the dissolution method and batch difference, then investigate formulation and process variables.
You correctly linked disintegration, wetting and compression to dissolution, but gave limited explanation of drug particle properties.
ImproveAdd particle size, solid-state form and solubility as possible contributors where relevant to the drug.
You named disintegration and dissolution tests, but did not explain that a test result needs interpretation alongside batch and method information.
ImproveSay what each test helps distinguish and compare results with the applicable specification and reference data.
A strong answerI would first confirm that the dissolution method, apparatus, medium and sampling were performed as specified, then compare the affected batch with the previous batch and its records. I would investigate drug-related factors such as particle size, solid-state form and solubility, as well as formulation factors that affect wetting or disintegration. I would review granulation, lubricant use and blending, compression force and tablet porosity because these can alter disintegration and liquid penetration. I would compare disintegration and dissolution results with other relevant quality data rather than treating either test as a complete explanation. Once I had evidence for a cause, I would assess its impact and follow the appropriate quality investigation and change-control process.
That is a MySummaries station, filled with pharmaceutics material. Yours is written from your own notes. Start free
This response is careful about cause. It does not assert that a particular excipient or process step is responsible before the evidence is checked. In your own answer, connect any proposed test to the question it helps resolve: for example, whether tablets are disintegrating differently, whether the drug is dissolving differently, or whether the method itself is reliable.
Station 2: Formulating an oral suspension
This station tests whether you can turn a formulation principle into practical choices. A suspension is a dispersion of insoluble solid particles in a liquid vehicle. Your answer should cover physical stability, dose uniformity and acceptability to the person taking it. Be specific about the problem each component is intended to address; simply listing excipient classes is not enough.
In your explanation, distinguish sedimentation from caking. Sedimentation can occur as dispersed particles settle; a well-designed product should be capable of being redispersed sufficiently for consistent dosing. Particle size, the difference in density between particles and vehicle, and the vehicle’s viscosity all influence settling. Increasing viscosity may slow settling, but the product must still be pourable and measurable. A wetting agent may help liquid spread over hydrophobic particles, while a suspending agent can help create a structured vehicle. The actual choice depends on the drug, other ingredients, intended use and evidence from development.
A marked oral attempt in MySummaries shows what a complete answer might cover and where a candidate needs more precision:
Examiner
You need to formulate an oral suspension of a poorly water-soluble drug. What would you consider, and how would you assess whether the product is suitable?
You selected a suspension appropriately for a poorly water-soluble drug and explained the role of a suspending agent.
ImproveAlso discuss wetting and the effect of particle properties on dispersion and settling.
You identified caking and the need to redisperse, but did not explicitly connect shaking and sampling to dose uniformity.
ImproveExplain how you would check redispersibility and whether doses taken from the container are consistent.
You suggested appearance and settling observations, but omitted a clear link to the intended container and use.
ImproveInclude suitable checks for physical stability, delivered dose and the product’s actual storage and administration conditions.
A strong answerI would choose a suspension if the drug cannot be delivered as a suitable solution, then establish the required dose, route, storage conditions and acceptable feel and taste. I would assess the drug’s particle size, wetting and tendency to aggregate, and select a vehicle that slows settling without making the product difficult to pour. The formulation should settle in a way that remains readily redispersible rather than forming a hard cake. I would assess appearance, sedimentation, redispersibility and dose uniformity after the labelled shaking and administration procedure, using a suitable container and measuring device. I would also consider chemical and microbiological stability and confirm that the final formulation remains suitable throughout its intended storage period.
The strongest answers connect formulation and use. A suspension that looks acceptable while undisturbed may still be unsuitable if it cannot be redistributed or if doses are inconsistent. Say how the product is meant to be shaken and measured, and explain what you would test. Do not invent a universal settling limit or preservative requirement: these depend on the product and relevant standards.
Station 3: Sterile product preparation
This station is a safety question as much as a formulation question. Separate the product’s formulation choices from the assurance of sterility. State that you would establish whether the ingredients and product tolerate a suitable terminal sterilisation process; if not, an appropriate aseptic manufacturing approach may be necessary. The choice must be based on product properties and validated processes, not convenience.
Make an important distinction: sterilisation does not automatically remove bacterial endotoxins. Endotoxin control and sterilisation are related to product safety but are not interchangeable. Your answer should also mention suitable controls for components, environment, equipment, process and finished product as applicable. The exact requirements depend on the product and governing standards, so check the applicable pharmacopoeia and local regulatory guidance rather than quoting a guessed temperature, time or acceptance limit.
A recorded viva in MySummaries can help you practise explaining those distinctions under a time limit:
Examiner
You are asked to prepare a sterile aqueous product for parenteral use. Talk me through the critical choices and controls, including what sterilisation can and cannot achieve.
You distinguished terminal sterilisation from aseptic processing, but did not make the choice depend explicitly on product compatibility and process validation.
ImproveExplain that the route depends on the product and that the selected process must be validated.
You mentioned environmental and component controls, but the answer did not clearly distinguish sterility from endotoxin control.
ImproveState directly that sterilisation does not necessarily remove endotoxins and that endotoxin risks need separate control.
You identified finished-product checks, but did not say that specific tests and limits depend on applicable standards.
ImproveName the relevant categories of verification and refer to the applicable product specification and official requirements.
A strong answerI would first establish the formulation, container and process constraints, including whether the product can tolerate a suitable terminal sterilisation process. If it cannot, I would consider an appropriate aseptic process using suitable sterile components and validated controls. I would not treat a sterility assurance step as a substitute for controlling endotoxins, because sterilisation does not necessarily remove them. I would consider contamination risks in materials, equipment, environment, personnel and processing, and identify the controls and verification required for the specific product. I would confirm the applicable pharmacopoeial and regulatory requirements rather than assume a universal process condition or acceptance limit.
Review the answer, not just the score
A percentage is only useful if you can identify the next action. After each attempt, ask: Did I name the decision I was making? Did I explain why? Did I identify a risk and a way to check it? If not, repeat the station with one improvement in mind. Do not try to memorise the model response as a script; practise making the same reasoning clear in your own words.
In the sterile-product answer, one phrase is worth being precise about. MySummaries can mark a portion of the transcript for review:
I would first check whether the formulation and container tolerate terminal sterilisation. If not, I would use aseptic processing. I would also assess endotoxin risk separately, because sterilisation does not necessarily remove endotoxins. Then I would confirm the process controls and tests required for the product.
If not, I would use aseptic processing.
The answer identifies a possible route but does not show that the process and components must be suitable and controlled.
Say: Say: If terminal sterilisation is unsuitable for the product, I would consider an appropriate aseptic process using suitable sterile components and validated controls.The improvement is not to add jargon. It is to make the condition and the required control explicit. When you review your own recordings, mark only a sentence that is vague, incomplete or incorrect. Then replace it with a precise statement you could deliver naturally.
A repeatable practice routine
Use a short cycle for each topic:
- Prepare: Write a one-line prompt from a lecture, practical or learning outcome.
- Answer aloud: Give yourself about three minutes, or use the time appropriate to your course.
- Review: Note one sound explanation, one missing detail and one unsupported claim.
- Retry: Answer again, changing the weak part rather than reproducing every sentence.
- Revisit: Return to the station later and check whether the answer has become clearer without becoming longer.
Rotate between formulation design, manufacturing, dosage-form performance, stability and quality control. Include both familiar topics and questions that force you to explain a trade-off. If you are unsure of a product-specific value or official standard, practise saying what information you would consult and how it would affect your decision. That is safer than supplying a confident but unverified number.
How MySummaries helps
MySummaries builds revision boards from your own PDFs, slides and photographed notes, then uses those materials to create recorded oral-exam practice. For pharmaceutics viva preparation, use your course content to make stations, answer them aloud, and review the marked response for missing reasoning, weak detail and claims to verify.